Remdesivir Authorized With Conditions For The Treatment Of Patients In Canada With Severe Covid-19 Symptoms
Recall Summary Remdesivir has been authorized in Canada for treating patients with severe COVID-19 symptoms, but this authorization comes with specific conditions that must be followed. This antiviral medication is available across Canada for eligible patients meeting the defined criteria for severe disease. Healthcare providers and patients receiving this treatment should be aware of the conditional nature of this authorization and any requirements associated with its use.
- Reason
- COVID
- Category
- consumer product recall
- Country
- Canada
- Agency
- HC-PRODUCTS
- Recall date
- 2020-07-28
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-PRODUCTS
Recall details on Nibble Recalls: https://trynibble.app/recalls/912d051f-4868-479c-a8bf-fc28448ff8e8